English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAs prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study finds that efforts to cap prescription drug spending are yielding significant out-of-pocket savings for these patients.
Tag: Medicare Part D
AMERICAN SOCIETY OF NEPHROLOGY APPLAUDS THE WAYS AND MEANS COMMITTEE FOR ADVANCING THE KIDNEY PATIENT ACT (HR 5074)
The American Society of Nephrology (ASN) commends congressional leaders on the House Ways and Means committee for advancing the Kidney PATIENT Act, bipartisan legislation to maintain patient access to oral-only medications by retaining coverage through Medicare Part D.
More than 500,000 patients undergoing dialysis require numerous medications to manage their health, and, for many patients this includes certain oral-only medications, such as phosphate binders. These vital oral-only medications are best dispensed by pharmacies, who have dedicated infrastructure suited to promoting at-home medication adherence and are more accessible to patients.
Mark Cuban Drug Company may offer savings for urology drugs
An online pharmacy offering standardized, transparent pricing can reduce out-of-pocket costs for patients taking common medications prescribed by urologists, suggests a study in the March issue of Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Requests for Brand Name Over Generic Prescription Drugs Cost the Medicare Program $1.7 Billion in a Single Year, Study Finds
The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health.